HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States.
$494.99-2.46%
报价 2026-11-06
市值
$103.4B
EV
$154.92B
PE (TTM)
16.4x
预期 PE (FY2026)
16.4x
52 周区间距高点 -9.2%
$361.32$545.13
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.0x | 29.97 → 31.34（1.0x） | 15.8 |
| FY+32028-12 | 1.1x | 29.97 → 34.93（1.2x） | 14.2 |
毛利率 22% · TTM 收入 $78701M · 基数 EPS 29.97（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| HCAHCA Healthcare, Inc. | $103.4B | -2.5% | +4.5% | 14.9% | 16.4x | 9.7x | 17.3x | |
| PFEPfizer Inc. | $167.51B | -0.2% | +1.4% | 72.8% | 37.3x | 17.7x | 14.7x | |
| VRTXVertex Pharmaceuticals Incorporated | $138.67B | +0.8% | +8.8% | 86.3% | 29.0x | 23.5x | 43.4x | |
| MDTMedtronic plc | $130.22B | -2.9% | +8.0% | 62% | 24.2x | 14.8x | – | |
| BMYBristol-Myers Squibb Company PFD CONV 2 | $127.02B | -1.6% | -1.5% | 67.7% | 16.5x | 10.5x | 9.9x | |
| SYKStryker Corporation | $124.02B | -2.8% | +8.8% | 63.5% | 39.2x | 24.7x | 28.9x | |
| MCKMcKesson Corporation | $123.68B | -1.0% | +6.6% | 3.6% | 24.9x | 17.6x | 12.2x | |
| SNYSanofi | $113.26B | +0.3% | – | 71.7% | 8.9x | 9.7x | – | |
| CVSCVS Health Corporation | $107.24B | +3.1% | +1.7% | 13.8% | 51.2x | 17.8x | 13.7x | |
| 同行中位数 | – | – | +6.6% | 65.6% | 26.9x | 17.6x | 14.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.85B | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B |
| Gross Margin | 14.9% | 15.2% | 15% | 41.9% | 41.8% | 41% | 41.3% | 41.4% |
| Operating Margin | 14.9% | 15.2% | 15% | 16.3% | 15.5% | 15.9% | 15.6% | 15.6% |
| Net Income | $1.58B | $1.7B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B |
| Diluted EPS | 7.27 | 7.62 | 7.15 | 8.14 | 6.96 | 6.83 | 6.45 | 5.63 |
| Operating Cash Flow | $4.46B | $2.34B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B |